BIO Adds Democratic Political Insider Matthew Schumaker to Its Advocacy Staff.WASHINGTON -- Jim Greenwood, President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of the Biotechnology Industry Organization Biotechnology Industry Organization or BIO was founded 1993 in Washington, DC. James C. Greenwood is BIO's current President. External links
Schumaker most recently served at the Democratic Congressional Campaign Committee The Democratic Congressional Campaign Committee (commonly referred to as the "D triple C," or the "D-Trip") is the Democratic Hill committee for the United States House of Representatives, working to elect Democrats to that body. , where he guided the Committee's independent expenditures in more than twenty competitive House races. Prior to moving to the DCCC DCCC Democratic Congressional Campaign Committee DCCC Delaware County Community College DCCC Derbyshire County Cricket Club DCCC Davidson County Community College (Lexington, North Carolina) DCCC Durham County Cricket Club , Schumaker served as the first ever Executive Director of the New Democrat Coalition The New Democrat Coalition is an organization within the United States Congress. It is made up of 20 Democratic Senate members and 44 Democratic members of the House of Representatives who claim moderate and pro-business stances. , the largest centrist coalition in the House of Representatives. Schumaker also previously served as Communications Director and Legislative Assistant for Representative Darlene Hooley Darlene Kay Olson Hooley (born April 4 1939) is a Democratic member of the U.S. House of Representatives from Oregon who represents the state's 5th congressional district. A native of North Dakota, she spent eight years teaching high school before entering politics when she was (D, OR). "BIO's advocacy operation represents one of the most strategic and transformational industries in the world. Matthew's strength of experience on Capitol Hill will further enhance our efforts to advocate on behalf of our 1,200 members before the White House, Congress and regulatory agencies," said Greenwood. "BIO is engaged with the new Congress and Administration as we work to ensure the proper policies and incentives are in place to further expand our nation's innovation economy. America remains the world leader in biotechnology innovation in the fields of cutting-edge health care, agriculture and environmental products, and BIO is proud of the industry it serves," Greenwood concluded. Upcoming BIO Events BIO CEO & Investor Conference 2009 February 9-10, 2009 New York New York, state, United States New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of , New York BIO-Europe Spring March 16-18, 2009 Milan, Italy BIO IP Counsels' Committee Conference March 25-27, 2009 Phoenix, AZ BIO National Venture Conference March 31-April 1,2009 Boston, MA BIO Windhover wind·hov·er n. Chiefly British A kestrel. 2009 April 13-15, 2009 New York, New York BIO-LES Business Development Basics Course May 15-17, 2009 Atlanta, GA BIO-LES Advanced Business Development Course May 15-17, 2009 Atlanta, GA BIO Executive Presentation Workshop May 17, 2009 Atlanta, GA 2009 BIO International Convention May 18-21, 2009 Atlanta, Ga. BioEquity Europe June 9-10, 2009 Munich, Germany World Congress on Industrial Biotechnology & Bioprocessing July 19-22, 2009 Montreal, Quebec, Canada About BIO BIO represents more than 1,200 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world's largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion